Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study.

ABSTRACT:

SUBMITTER: Marfella R 

PROVIDER: S-EPMC8653151 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature